HIGHLIGHTS
- who: Noelia Márquez Pete et al. from the Pharmacy Service, Pharmacogenetics Unit, University Hospital Virgen las Nieves, Granada, Spain have published the paper: Influence of the FCGR2A rs1801274 and FCGR3A rs396991 Polymorphisms on Response to Abatacept in Patients with Rheumatoid Arthritis, in the Journal: (JOURNAL)
- what: This study showed that high-affinity FCGR2A-p.131His variant low-affinity FCGR3A-p.158Phe variant and combined use of FCGR2A/FCGR3A genetic variations could affect ABA effectiveness. Within this conceptual framework, the objective of this study was to evaluate the involvement of the FCGR2A rs1801274 and FCGR3A . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.